Safety of bisphosphonates in women of child bearing age.
McKenna
M
M
Mansfield
J C
JC
D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects* / Q000627:therapeutic use; D010024:Osteoporosis / Q000139:chemically induced; D011247:Pregnancy
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D006887:Hydroxycholecalciferols; C008088:alfacalcidol; D019386:Alendronate